Tuune, a femtech startup revolutionizing women’s health by offering individualized hormonal analysis and birth control, has announced the closing of a $4.6M fundraising round to launch in the U.S. market. The investment, led by venture capital firm Octopus Ventures, will support Tuune’s efforts to build a more individualized medical system that puts hormones first, transforming the future of healthcare for all women…
Louise Klintner, who some of you may know from her work with Impact Fund The Case for Her, has recently published a study titled “Normalizing the Natural: A study of menstrual product destigmatization” and we’re excited to share a summary of her finding with you in a guest post today. Read on and learn more about how product stigma can have a…
UK-based femtech startup The Lowdown has raised a $800K pre-seed round to built out its community based contraception and women’s health platform. The round was led by Calm/Storm Ventures with participation from Nina Capital and angel investors. Entrepreneur First followed on from their initial investment in 2020. Since its founding in 2019 The Lowdown has built an engaged community around its mission…
Fertility company Kindbody has appointed Dean Morbeck, Ph.D. as its first Chief Scientific Officer. Dr. Morbeck is a leading researcher in the area of In Vitro Fertilization (IVF) and brings more than 25 years of experience in the field to the company. He will apply his scientific expertise and highly specialized areas of research to support Kindbody’s full-service family-building service offering as the…
“Everytime I would go to dinner with my friend, we would be in the car for about five minutes before her birth control alarm went off. When it went off, it always went one of two ways – she would skip her pill, or we would turn around to grab her pill, ultimately missing dinner”, shares Sammie Hasen a Georgia Tech student…
Power to Decide is a private, non-partisan, non-profit organization in the U.S. that works to ensure all people, no matter who they are, where they live or what their economic status might be, have the power to decide if, when and under what circumstances to get pregnant or have a child. This week the organization announced the inclusion of telehealth abortion providers in…
It’s World Contraception Day on Sunday and as every year the goal is to spread the word and raise awareness about contraception and safe sex, to help each new generation of adults make informed decisions until every pregnancy in the world is a planned one. And we’re excited to be teaming up with UK-based startup The Lowdown on this mission this year.…
Biotech company Progenity has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,112,403 for assessment of preeclampsia using assays for free and dissociated placental growth factor to the company. The patent is directed to methods, compositions, and kits for detecting and measuring free and dissociated placental growth factor (PlGF) levels in biological samples. PlGF is…
